Clinical Trials
2 trialsNCT05296564 2025-10-02
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Hadassah Medical Organization
Phase 1/2 Recruiting
NCT05821686 2025-02-12
Efficacy of Interleukin-2 in Triple Negative Breast Cancer
Nova Scotia Health Authority
Phase 1/2 Not yet recruiting